HER2 amplification occurs due to genetic mutations that result in multiple copies of the HER2 gene within the cancer cells. This genetic alteration can lead to uncontrolled cell growth and division, making the cancer more aggressive. The amplification can be detected through genomic testing methods such as fluorescence in situ hybridization (FISH) or immunohistochemistry (IHC).